Fig. 3: Forest plot for subgroup analyses of overall survival. | Nature Communications

Fig. 3: Forest plot for subgroup analyses of overall survival.

From: Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2)

Fig. 3: Forest plot for subgroup analyses of overall survival.

Dots represent the cohort-specific hazard ratios with error bars corresponding to 95% CI bounds, which were calculated by using the univariate Cox regression model. ECOG PS Eastern Cooperative Oncology Group performance status, HR hazard ratio, CI confidence interval.

Back to article page